Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosamprenavir/Ritonavir in Pediatric HIV-1 Infection
NCT00040664Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Jul 2002
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of fosamprenavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Jul 2002; status: completed.
02
Drugs
fosamprenavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00040664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040664.